Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1957 1
1958 1
1966 6
1967 1
1968 7
1969 5
1970 5
1971 7
1972 6
1973 7
1974 9
1975 11
1976 12
1977 6
1978 19
1979 16
1980 11
1981 14
1982 11
1983 10
1984 28
1985 19
1986 24
1987 26
1988 35
1989 25
1990 47
1991 29
1992 25
1993 42
1994 45
1995 51
1996 43
1997 66
1998 63
1999 37
2000 54
2001 69
2002 60
2003 57
2004 73
2005 71
2006 80
2007 85
2008 87
2009 110
2010 121
2011 128
2012 134
2013 197
2014 154
2015 155
2016 130
2017 140
2018 132
2019 127
2020 109
2021 116
2022 94
2023 86
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

3,032 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Skin Vascular Neoplasm"
Page 1
Infantile hemangioma. Part 2: Management.
Sebaratnam DF, Rodríguez Bandera AL, Wong LF, Wargon O. Sebaratnam DF, et al. J Am Acad Dermatol. 2021 Dec;85(6):1395-1404. doi: 10.1016/j.jaad.2021.08.020. Epub 2021 Aug 19. J Am Acad Dermatol. 2021. PMID: 34419523 Review.
Where the IH involutes with cutaneous sequelae, a range of interventions have been reported, including surgery, laser, and embolization. IHs have a well-described clinical trajectory and are readily diagnosed and managed via telemedicine. ...
Where the IH involutes with cutaneous sequelae, a range of interventions have been reported, including surgery, laser, and embolization. IHs …
Infantile Hemangioma: An Updated Review.
Leung AKC, Lam JM, Leong KF, Hon KL. Leung AKC, et al. Curr Pediatr Rev. 2021;17(1):55-69. doi: 10.2174/1573396316666200508100038. Curr Pediatr Rev. 2021. PMID: 32384034 Review.
BACKGROUND: Infantile hemangiomas are the most common vascular tumors of infancy, affecting up to 12% of infants by the first year of life. ...METHODS: A Pubmed search was conducted in November 2019 in Clinical Queries using the key term "infantile hemangioma". The …
BACKGROUND: Infantile hemangiomas are the most common vascular tumors of infancy, affecting up to 12% of infants by the first year of …
Infantile Hemangiomas.
Hasbani DJ, Hamie L. Hasbani DJ, et al. Dermatol Clin. 2022 Oct;40(4):383-392. doi: 10.1016/j.det.2022.06.004. Epub 2022 Sep 16. Dermatol Clin. 2022. PMID: 36243426 Review.
Infantile hemangiomas (IHs) are the most common benign vascular tumors of childhood. They develop during the first few weeks of life and naturally progress by proliferating over several months before they involute and resolve; this renders them inconsequential in many case …
Infantile hemangiomas (IHs) are the most common benign vascular tumors of childhood. They develop during the first few weeks of life …
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
Muñoz-Garza FZ, Ríos M, Roé-Crespo E, Bernabeu-Wittel J, Montserrat-García MT, Puig L, Gich I, Baselga E. Muñoz-Garza FZ, et al. JAMA Dermatol. 2021 May 1;157(5):583-587. doi: 10.1001/jamadermatol.2021.0596. JAMA Dermatol. 2021. PMID: 33825828 Free PMC article. Clinical Trial.
OBJECTIVE: To evaluate the efficacy and safety of timolol maleate solution, 0.5%, for the early treatment of IH in infants younger than 60 days. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, randomized, double-blind, placebo-controlled, phase 2a pilot clinical …
OBJECTIVE: To evaluate the efficacy and safety of timolol maleate solution, 0.5%, for the early treatment of IH in infants younger than 60 d …
Infantile Hemangioma: A Current Review.
Pahl KS, McLean TW. Pahl KS, et al. J Pediatr Hematol Oncol. 2022 Mar 1;44(2):31-39. doi: 10.1097/MPH.0000000000002384. J Pediatr Hematol Oncol. 2022. PMID: 34966091 Review.
Infantile hemangiomas (IHs) are common vascular lesions which are benign but can cause significant functional and cosmetic morbidity. ...Therefore, early recognition and referral, if necessary, are important. Continued research on IH, both basic science and clinical …
Infantile hemangiomas (IHs) are common vascular lesions which are benign but can cause significant functional and cosmetic morbidity. …
Vascular Lesions.
Slaughter KA, Chen T, Williams E 3rd. Slaughter KA, et al. Facial Plast Surg Clin North Am. 2016 Nov;24(4):559-571. doi: 10.1016/j.fsc.2016.06.009. Facial Plast Surg Clin North Am. 2016. PMID: 27712821 Review.
Classification of vascular lesions based of off the biological behavior has greatly facilitated more accurate diagnoses, optimally defined treatment plans, and better outcomes. Treatment of vascular lesions has taken a more conservative surgical approach with relian …
Classification of vascular lesions based of off the biological behavior has greatly facilitated more accurate diagnoses, optimally de …
Laser treatment of infantile hemangioma.
Ziad K, Badi J, Roaa Z, Emily AH. Ziad K, et al. J Cosmet Dermatol. 2023 Jun;22 Suppl 2:1-7. doi: 10.1111/jocd.15671. Epub 2023 Feb 12. J Cosmet Dermatol. 2023. PMID: 36774645 Review.
CONCLUSION: There are many laser systems used for the treatment of hemangioma and vascular tumors. These laser systems are of different wavelengths and penetration depths, however, they operate by similar mechanisms and in some cases two or more lasers can be applied durin …
CONCLUSION: There are many laser systems used for the treatment of hemangioma and vascular tumors. These laser systems are of differe …
Angioadnexocentric nevus.
Hashimoto K, Amano M, Setoyama M. Hashimoto K, et al. J Dermatol. 2012 Nov;39(11):909-15. doi: 10.1111/j.1346-8138.2012.01599.x. Epub 2012 Jul 4. J Dermatol. 2012. PMID: 22762690
It is postulated that intradermal nevus cells of fetal skin freely migrate through mesenchymal tissue and stop when they hit barriers such as blood vessels and eccrine ducts and propagate in situ. How does this random migration theory explain the blood vessel …
It is postulated that intradermal nevus cells of fetal skin freely migrate through mesenchymal tissue and stop when they hit b …
Treatment of radiation-associated angiosarcoma.
Dufresne A, Meeus P, Sunyach MP. Dufresne A, et al. Curr Opin Oncol. 2023 Jul 1;35(4):296-300. doi: 10.1097/CCO.0000000000000958. Epub 2023 May 12. Curr Opin Oncol. 2023. PMID: 37222197 Review.
SUMMARY: Immune therapy represents the most promising treatment under development. At the time of building clinical trial to assess the efficacy of immune therapy, the lack of randomized studies prevents the identification of a strong and consensual reference …
SUMMARY: Immune therapy represents the most promising treatment under development. At the time of building clinical trial to a …
Management of Cutaneous Angiosarcoma: an Update Review.
Bi S, Zhong A, Yin X, Li J, Cen Y, Chen J. Bi S, et al. Curr Treat Options Oncol. 2022 Feb;23(2):137-154. doi: 10.1007/s11864-021-00933-1. Epub 2022 Feb 19. Curr Treat Options Oncol. 2022. PMID: 35182299 Review.
3,032 results